azathioprine has been researched along with Short Bowel Syndrome in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Short Bowel Syndrome: A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gutzler, F | 1 |
| Zimmermann, R | 1 |
| Ring, GH | 1 |
| Sauer, P | 1 |
| Stiehl, A | 1 |
1 other study available for azathioprine and Short Bowel Syndrome
| Article | Year |
|---|---|
Ursodeoxycholic acid enhances the absorption of cyclosporine in a heart transplant patient with short bowel syndrome.
Topics: Administration, Oral; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Administrat | 1992 |